Sign Up to like & get
recommendations!
1
Published in 2022 at "Oncogene"
DOI: 10.1038/s41388-022-02293-y
Abstract: SMAD4 loss-of-function mutations have been frequently observed in colorectal cancer (CRC) and are recognized as a drug target for therapeutic exploitation. In this study, we performed a synthetic lethal drug screening with SMAD4-isogenic CRC cells…
read more here.
Keywords:
crc cells;
crc;
smad4 crc;
smad4 ... See more keywords